Singh Maneesh, Nangia Sapna, Cudahy Terence, Mir Ruquaya
Radiation Oncology, Apollo Cancer Institute, Indraprastha Apollo Hospital, New Delhi, India.
Ameripath Labs, Indianapolis, Indianapolis, Indiana, USA.
BMJ Case Rep. 2018 Sep 8;2018:bcr-2018-226380. doi: 10.1136/bcr-2018-226380.
The cornerstone modality of treatment of central mucoepidermoid carcinoma (CMEC) of the mandible is surgery, optimally, an en bloc resection with/without segmental or hemimandibulectomy. Notwithstanding the documentation of a survival benefit in few case reports with the addition of postoperative radiotherapy in carefully selected high-risk patients, there does not exist a clearly defined consensus regarding the role of adjuvant radiotherapy. We report the case of a 49-year-old man who presented with right lower jaw swelling which on imaging was found to be a multiloculated lesion causing bony expansion and cortical destruction of the mandible and was diagnosed with CMEC after radiological and histopathological criteria were met. He underwent right hemimandibulectomy and histopathology showed squamous and mucinous cells with positive mucicarmine staining and characteristic immunohistochemistry markers confirming the diagnosis of CMEC. He subsequently underwent adjuvant radiotherapy and is disease free 5 years since treatment completion.
下颌骨中央黏液表皮样癌(CMEC)的主要治疗方式是手术,理想情况下是整块切除,可进行或不进行节段性或半侧下颌骨切除术。尽管在少数病例报告中记录了在精心挑选的高危患者中术后放疗可带来生存获益,但关于辅助放疗的作用尚无明确共识。我们报告了一例49岁男性患者,其因右下颌肿胀就诊,影像学检查发现是一个多房性病变,导致下颌骨骨质膨胀和皮质破坏,在满足放射学和组织病理学标准后被诊断为CMEC。他接受了右侧半侧下颌骨切除术,组织病理学显示有鳞状和黏液细胞,黏液卡红染色阳性,特征性免疫组化标记物确诊为CMEC。他随后接受了辅助放疗,自治疗完成后5年无疾病复发。